SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 23 filers reported holding SILENCE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |